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Summary.-The VX2 carcinoma has been used extensively as an experimental
model for different aspects of tumour behaviour and is usually maintained by serial
intramuscular injections of tumour cells. The tumour grows rapidly, infiltrating
between muscle bundles into the fibrous tissue replacing ischaemic muscle and into
the vascular tree. The most interesting method of spread occurs within the sarco-
lemma and this may be responsible for the rounded cell nests described in this
tumour.
THE VX2 carcinoma is a laboratory
tumour which has been used extensively
as an experimental model for different
aspects of tumour behaviour. It is a
product of a virus induced papilloma of
rabbits (Shope and Hurst, 1933). In
1935, Rous and Beard reported the pro-
gression of the papilloma to carcinoma in
domestic rabbits, and in some cases the
tumour revealed frank anaplasia with
frequent metastases. Kidd and Rous
(1940) showed that a squamous cell
carcinoma derived from the original papil-
loma could be propagated easily in
skeletal muscle. However, in 1952 Rous
and his colleagues (Rous, Kidd and
Smith, 1952) noted the loss of viral
dependency of the tumour and demon-
strated the absence of complement fixing
antibodies in these rabbits. The VX2
carcinoma has since been free of viral
characteristics and remains readily
transmissible.
We have been using the tumour to
study the reaction of bone to metastatic
cancer (Galasko, 1972), and the bio-
chemical properties of tumour cells after
various therapeutic regimens (Muckle and
Dickson, 1973). During the past 4 years
the VX2 tumour has been maintained in
our laboratory by serial intramuscular
injection of tumour cells into the thigh
muscles of New Zealand white rabbits.
During this period we have noted some
unusual manifestations of local growth
which, as far as we are aware, have not
been reported previously.
MATERIAL AND METHODS
The VX2 carcinoma was transplanted at
monthly intervals with a 9900 success rate.
On each occasion 1 ml of tumour cell sus-
pension containing approximately 2.5 x 106
cells was injected, the viability being 80-95%
as assessed by trypan blue. The tumour
metastasized readily to the regional lymph
nodes and lungs, but rarely to other sites.
Host death occurred from pulmonary meta-
stases or hypercalcaemia.
On each occasion 1 mm cubes of the
tumour and surrounding muscie Nere imme-
diately fixed in 3% gluteraldehyde in
cacodylate buffer at pH 7-4. After post-
fixation, dehydration and embedding in epon
resin, sections were cut, stained with 100
uranyl acetate in alcohol and Reynold's lead
citrate and examined in a Phillips EM100
electron microscope.
Further slices of the tumour and sur-
rounding soft tissue were fixed in neutral
formalin and after preparation stained with
haematoxylin and eosin and examined with a
light microscope.
RESULTS
The tumour grew rapidly in skeletal
muscle and by 4 weeks after inoculation it
had reached 4-5 cm in diameter. The
centre of the tumour was necrotic with a
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FIG. 1. The VX2 carcinoma (T) infiltrating tissue plane between muscle bundles (M).
FIG. 2(a). VX2 carcinoma cells lying in the centre of muscle fibres (arrowed) which are not
connected with the main tumour mass (T).
FIG. 2(b). The area marked off in Fig. 2(a) under a higher magnification.
FIa. 3. The discrete rounded cell nest appearance of the VX2 carcinoma which is the result of
proliferation of cells lying within the sarcolemmal membrane.
FIG. 4. Electron microscope section showing nuclei of the VX2 carcinoma (arrowed) lying within a
degenerating muscle cell. ( x 8200.)
FIG. 5. Nuclei (N) of the VX2 carcinoma can be seen lying within a degenerating muscle cell. The
cytoplasm (C) immediately surrounding the VX2 nuclei appears different to the cytoplasm in the
rest of the c3ll but no discrete membrane can be found between the two. The sarcolemmal
membrane (M) is intact. (x 8200.)
FIG. 6.-VX2 carcinoma cell nucleus lying (N) in degenerating muscle fibre close to the intact
sarcolemmal membrane (M). (x 10,900.)
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3-4 mmrimofviableandactivecarcinoma.
During its growth the tumour seemed to
invade muscle in several ways. First, it
compressed the blood supply so that large
areas of muscle were rendered ischaemic,
eventually becoming replaced by fibrous
tissue; subsequently, the VX2 tumour
invaded into this fibrous tissue. Secondly,
the tumour grew along tissue planes,
infiltrating between muscle bundles (Fig.
1) and applying itself closely to the sar-
colemma without obvious invasion. Sub-
sequent tumour growth led to atrophic
changes in the adjacent muscle fibres and
their eventual replacement.
Tumour cells were also found in the
blood vessels and in the perivascular
lymphatics, having gained access either
by direct invasion or embolization. This
intravascular spread was not surprising
sincethe hostrabbits died from metastases
at 5-6 weeks following inoculation of the
VX2 cells.
The most interesting mode of spread
occurred within the sarcolemma. Clumps
of tumour cells were seen in muscle fibres
some distance away from the main bulk of
tumour, with no obvious direct communi-
cation between the muscle fibres and the
main tumour bulk (Fig. 2). The subse-
quent multiplication of VX2 cells within
the sarcolemmal sheath was responsible
for the discrete, rounded cell nests
described in this tumour (Fig. 3).
Electron microscopic studies of the
affected fibres showed that in all instances
there was cytoplasmic and nuclear degen-
erationinthemuscle cell.In someinstances
the sarcolemmal membrane appeared to be
intact but in other cases it had disappeared
(Fig. 4, 5, 6).
DISCUSSION
The method of access used by the
tumour cells to invade the muscle fibres is
not known and, although Volkmann
(1870) suggested that cancer cells may
enter through a traumatized area in the
sarcolemma, several hundred electron and
light microscope sections failed to reveal
actual tumour cell invasion. Commonly
the VX2 cell was seen applied to the
sarcolemmal membrane.
Muckle (unpublished data) found that
when he injected tumour cell suspensions
(5 x 105 cells) of the VX2 carcinomainto
the femoral artery or the aorta of New
Zealand white rabbits, the animals deve-
loped multiple metastases. Forty per
cent of the animals developed metastases
in the thigh muscles. When the muscle
was traumatized or denervated by neu-
rectomy, the incidence of metastases at
this site increased to 70%. He suggested
that the rapid transit of the VX2 cells
across the muscle microcirculation was
responsible for the relatively low incidence
of muscle metastases and that this quick
movement was lost following denervation
or traumatization of the thigh muscle,
and resulted in a higher incidence of
muscle metastases.
The infrequency of skeletal muscle
metastases in disseminated neoplasia re-
mains a puzzling, yet intriguing, pheno-
menon since direct invasion of muscle by
growing tumour is not uncommon (e.g.,
invasion of the pectoral muscles by breast
carcinoma). One wonders whether with
more careful post mortem techniques
small muscle metastases may not be found
more frequently, although Willis (1934,
1941) carried out a detailed study of
this problem without reaching a firm
conclusion or discovering multiple muscle
metastases.
There have been very infrequent
reports of intrasarcolemmal tumour
growth (Hartz and van der Sar, 1942;
Hassin, 1947) but as far as we are aware
this has not previously been described
with the VX2 carcinoma.
We would like to thank Joan Farmer,
for the preparation of the electron micro-
scope sections and Darrel Haynes and
his stafffor the preparation of the light
microscopic material.
REFERENCES
GALASKO, C. S. B. (1972) Skeletal Metastases and
Mammary Cancer. Ann. R. Coll. Surg. Engl.,
50, 3.INTRASARCOLEMMAL PROLIFERATION OF THE vx2 CARCINOMA 65
HARTZ, P. H. & VAN DER SAR, A. (1942) Chloro-
leukaemia. Am. J. Path., 18, 715.
HASSIN, G. B. (1947) Carcinoma of Muscle Tissue as
a Cause of Laryngeal Paralysis. J. Neuropath.
exp. Neurol., 6, 358.
KIDD, J. G. & Rous, P. (1940) Transplantable
Rabbit Carcinoma Originating in a Virus-
induced Papilloma and Containing the Virus in
Masked or Altered Form. J. exp. Med., 71, 813.
MUCKLE, D. S. & DICKSON, J. A. (1973) Hyper-
thermia (42°C) as an Adjuvant to Radiotherapy
and Chemotherapy in the Treatment of Allo-
geneic VX2 Carcinoma in the Rabbit. Br. J.
Cancer, 27, 307.
Rous, P. & BEARD, J. W. (1935) Progression to
Carcinoma of Virus-induced Rabbit Papillomas
(Shope). J. exp. Med., 62, 523.
Rous, P., KIDD, J. G. & SMITH, W. E. (1952)
Experiments on Cause of Rabbit Carcinomas
Derived from Virus-induced Papillomas. Loss by
VX2 Carcinoma of Power to Immunize Hosts
against Papilloma Virus. J. exp. Med., 96, 159.
SHOPE, R. E. & HURST, E. W. (1933) Infectious
Papillomatosis of Rabbits with Note on Histo-
pathology. J. exp. Med., 58, 607.
VOLKMANN, R. (1870) Zur Histologie des Muskel-
krebses. Virchow8 Arch. path. Anat. Physiol.,
50, 543.
WILLIS, R. A. (1934) The Spread of Tumours in the
Human Body. London: Churchill. (Baker
Institute of Medical Research Monographs No. 2).
WILLIS, R. A. (1941) A Review of 500 Consecutive
Cancer Autopsies. Med. J. Aust., 2, 258.